Western Blot Assay for Antibodies to Borrelia burgdorferi, 1st Edition
This document addresses technical and interpretive considerations for use of Western blot assays that detect antibodies to Borrelia burgdorferi and other Borrelia species that cause Lyme Disease.
This document is available in electronic format only.
Members: $54.00 → $153.00Nonmembers: $180.00
Chairholder: Alan G. Barbour, M.D.
Date of Publication: October 1, 2000
ISBN Number: 1-56238-415-5
Order Code PDF: M34AE
Order Code Print: print not available
M34 Additional Details
The U.S. Food and Drug Administration (FDA) has evaluated and recognized this approved-level consensus guideline for use in satisfying a regulatory requirement.
This document is no longer being reviewed as part of our consensus process. However, because of its usefulness to a limited segment of the healthcare community, we are continuing to make the document available for its informational content.